Cyril Amarchand Mangaldas advises Swiss Parenterals Limited in acquisition of its 30% stake by Eris Lifesciences Limited
Cyril Amarchand Mangaldas advised Swiss Parenterals Limited and its promoter on the sale of the remaining 30% stake to Eris Lifesciences Limited through a preferential allotment deal worth ₹423.30 crore.